Depending on the target of the specific TRIM protein, increased expression of certain TRIM family members (e.g., TRIM25, TRIM27, and TRIM29) in tumor tissue promotes oncogenesis, and this has been correlated with poor clinical outcomes. The gene discussed is TRIM29; the disease is neoplasm.